Certara Reports Third Quarter 2026 Financial Results

Certara, Inc. (CERT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Certara Reports Third Quarter 2026 Financial Results Certara delivers a solid quarter with double-digit software revenue growth Updates 2026 financial outlook Appoints Grant Peterson Chief Product Officer Company to host conference call and webcast today at 8:30 a.m.

Event · Earnings
Also in this documentGuidance · 2%–3%

Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.

Original reporting
Published Nov 5, 2026, 12:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 12:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CERT
Bullish
high confidence
Mentioned
$CERT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CERTBullishHigh
01

Why it matters

The earnings release narrows the loss and shows strong software growth, which could support the stock.

02

Market read

First‑report earnings with improved loss and software growth provide a fresh catalyst for CERT.

03

What to watch

Higher operating expenses and a modest services decline could temper enthusiasm.

Relevance 7/10Novelty 8/10Timing: today
AlphAI · Earnings readCERT · third quarter 2026 · ended September 30, 2026

Certara delivers a solid quarter with double-digit software revenue growth and narrows its 2026 full-year revenue growth range to 2% to 3%.

✓Solid quarter

Third-quarter revenue grew 4%, software revenue grew 11%, adjusted EBITDA rose 6% and adjusted EBITDA margin reached 31.8%. Services revenue declined 2%, however, and the company reported a GAAP loss from continuing operations of $3.6 million.

Revenue
$94.9M
4% y/y
Software
$48.8M
11% on a reported basis y/y
EPS · non-GAAP
$0.09
full-year 2026 outlook
revenue growth range of 2% to 3%

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Total revenue, three months ended September 30, 2026GAAP$94.9M–4%
Software revenue, three months ended September 30, 2026GAAP$48.8M–11%
Services revenue, three months ended September 30, 2026GAAP$46.1M–decrease of 2%
Total bookings, three months ended September 30, 2026other$92.5M–4%
Software bookings, three months ended September 30, 2026other$46.9M–15%
Services bookings, three months ended September 30, 2026other$45.6M–decrease of 5%
Total cost of revenues, three months ended September 30, 2026GAAP$31.4M–decrease of $2.0 million
Total operating expenses, three months ended September 30, 2026GAAP$61.1M–increase of $3.1 million
Income from operations, three months ended September 30, 2026GAAP$2.32M––
Loss from continuing operations, net of tax, three months ended September 30, 2026GAAP−$3.6M–improvement of 26%
Net income attributable to common stockholders, three months ended September 30, 2026GAAP$5.59M––
Diluted loss per share from continuing operations, three months ended September 30, 2026GAAP$(0.02)––
Diluted earnings per share attributable to common stockholders, three months ended September 30, 2026GAAP$0.04––
Adjusted EBITDA, three months ended September 30, 2026non-GAAP$30.2M–6%
Adjusted EBITDA margin, three months ended September 30, 2026non-GAAP31.8%up more than 370 basis points from the second quarter–
Adjusted net income, three months ended September 30, 2026non-GAAP$13.5M–decrease of $0.3 million
Adjusted diluted earnings per share, three months ended September 30, 2026non-GAAP$0.09––
Total revenue, nine months ended September 30, 2026GAAP$282.3M––
Software revenue, nine months ended September 30, 2026GAAP$147.4M––
Services revenue, nine months ended September 30, 2026GAAP$134.9M––
Total bookings, nine months ended September 30, 2026other$288M––
Software bookings, nine months ended September 30, 2026other$146.3M––
Services bookings, nine months ended September 30, 2026other$141.6M––
Loss from continuing operations, net of tax, nine months ended September 30, 2026GAAP−$21.5M––
Net loss attributable to common stockholders, nine months ended September 30, 2026GAAP−$58.44M––
Diluted loss per share from continuing operations, nine months ended September 30, 2026GAAP$(0.14)––
Diluted loss per share attributable to common stockholders, nine months ended September 30, 2026GAAP$(0.38)––
Adjusted EBITDA, nine months ended September 30, 2026non-GAAP$83.1M––
Adjusted net income, nine months ended September 30, 2026non-GAAP$35.1M––
Adjusted diluted earnings per share, nine months ended September 30, 2026non-GAAP$0.23––
Trailing twelve-month total bookingsother$409.2M–increase of 2%
Trailing twelve-month software bookingsother$202.4M–increase of 8%
Trailing twelve-month services bookingsother$206.8M–decrease of 2%
Trailing twelve-month services book-to-billother1.15––

Segments

SegmentRevenueq/qy/y
SoftwareSoftware revenue grew 11% organically, described as the Company's first double-digit quarter in two years.$48.8M–11% on a reported basis
ServicesThe Company is working to convert its pipeline into bookings and revenue.$46.1M–decrease of 2% on a reported basis

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

full-year 2026 outlook

  • Revenuerevenue growth range of 2% to 3%
  • Tax rate25% to 30%
  • NoteSoftware revenue growth is expected to be above this range.
  • NoteServices revenue growth is expected to be at or below the low end of that range.
  • NoteAdjusted EBITDA margin outlook of 29% to 31%; the Company believes this remains an appropriate range for the fourth quarter.
  • NoteAdjusted diluted earnings per share of $0.31 to $0.34.
  • NoteFully diluted weighted average shares outstanding of 155 million to 157 million.

Capital returns

  • Common stock repurchase program: $(57,389) (in thousands) for the nine months ended September 30, 2026, compared to $(38,674) (in thousands) for the nine months ended September 30, 2025.
  • Treasury stock at cost: $(128,145) (in thousands) at September 30, 2026, compared to $(66,663) (in thousands) at December 31, 2025.

What drove it

  • Software revenue was $48.8 million and software bookings were $46.9 million, representing year-over-year growth of 11% and 15%, respectively.
  • Cost of revenues declined by $2.0 million, primarily due to lower equity-based compensation expense, professional and consulting expenses, and equipment and software expense.
  • Operating actions implemented in the first half produced initial benefits, according to the Interim Chief Financial Officer.
  • Adjusted EBITDA margin improved to 31.8%, up more than 370 basis points from the second quarter.
  • The Regulatory and Medical Writing business was divested on May 8, 2026 and is reported as discontinued operations.

Concerns

  • Services revenue was $46.1 million, a year-over-year decrease of 2%, while services bookings were $45.6 million, a year-over-year decrease of 5%.
  • Loss from continuing operations for the nine months ended September 30, 2026 was $(21.5) million, compared to $(1.8) million in the prior-year period.
  • Adjusted EBITDA for the nine months ended September 30, 2026 was $83.1 million, compared to $84.0 million in the prior-year period.
  • Total operating expenses increased by $3.1 million, driven primarily by higher employee-related costs, equipment and software expense, executive recruiting expense, amortization and depreciation expense, and professional and consulting expenses.
  • The Company continues to expect services revenue growth at or below the low end of its full-year revenue growth range.

What to watch

  • Conversion of the services pipeline into bookings and revenue.
  • Whether software revenue growth remains above the 2% to 3% full-year total revenue growth range.
  • Fourth-quarter adjusted EBITDA margin performance against the 29% to 31% range.
  • Execution of portfolio investments under newly appointed Chief Product Officer Grant Peterson.
  • Full-year adjusted diluted earnings per share performance against the updated $0.31 to $0.34 range.

Balance sheet and cash flow

  • Cash and cash equivalents: $214.9 million at the end of the third quarter.
  • Cash and cash equivalents: $214,932 (in thousands) at September 30, 2026, compared to $189,392 (in thousands) at December 31, 2025.
  • Long-term debt, net of current portion and debt discount: $288,248 (in thousands) at September 30, 2026, compared to $290,131 (in thousands) at December 31, 2025.
  • Current portion of long-term debt: $2,963 (in thousands) at September 30, 2026 and $2,963 (in thousands) at December 31, 2025.
  • Cash provided by operating activities, continuing operations: $46,264 (in thousands) for the nine months ended September 30, 2026, compared to $51,369 (in thousands) for the nine months ended September 30, 2025.
  • Cash from continuing operations in the third quarter: $30.7 million.
  • Capital expenditures: $(2,022) (in thousands) for the nine months ended September 30, 2026, compared to $(757) (in thousands) for the nine months ended September 30, 2025.
  • Capitalized software development costs: $(20,697) (in thousands) for the nine months ended September 30, 2026, compared to $(18,770) (in thousands) for the nine months ended September 30, 2025.
  • Cash used in investing activities, continuing operations: $(22,719) (in thousands) for the nine months ended September 30, 2026, compared to $(19,527) (in thousands) for the nine months ended September 30, 2025.
  • Payments on long-term debt: $(2,222) (in thousands) for the nine months ended September 30, 2026, compared to $(2,250) (in thousands) for the nine months ended September 30, 2025.
  • Net cash used in financing activities: $(83,252) (in thousands) for the nine months ended September 30, 2026, compared to $(59,173) (in thousands) for the nine months ended September 30, 2025.

Analysis

Certara reported a solid third quarter from continuing operations, with total revenue of $94.9 million, up 4%, led by software revenue of $48.8 million, up 11%. The software result was the Company's first double-digit organic software growth quarter in two years. Services remained the offset, with revenue of $46.1 million, down 2%, and services bookings of $45.6 million, down 5%.

Bookings showed the same mix shift. Total bookings increased 4% to $92.5 million, while software bookings increased 15% to $46.9 million. Services bookings declined 5%. On a trailing twelve-month basis, total bookings were $409.2 million, up 2%; software bookings were $202.4 million, up 8%; and services bookings were $206.8 million, down 2%. The trailing twelve-month services book-to-bill was 1.15.

Profitability improved in the quarter. Cost of revenues declined by $2.0 million to $31.4 million, while operating expenses increased by $3.1 million to $61.1 million. The company generated income from operations of $2,324 (in thousands), compared with a loss from operations of $(562) (in thousands) a year earlier. The GAAP loss from continuing operations narrowed to $3.6 million from $4.8 million, and adjusted EBITDA increased to $30.2 million from $28.6 million. Adjusted EBITDA margin was 31.8%, compared with 31.5% in the prior-year quarter and up more than 370 basis points from the second quarter.

Cash generation and capital allocation were notable. The Interim Chief Financial Officer said Certara generated $30.7 million of cash from continuing operations in the quarter and ended with $214.9 million in cash. For the nine months ended September 30, 2026, continuing-operations cash provided by operating activities was $46,264 (in thousands), capital expenditures were $(2,022) (in thousands), capitalized software development costs were $(20,697) (in thousands), and common-stock repurchases were $(57,389) (in thousands). Long-term debt, net of current portion and debt discount, was $288,248 (in thousands) at September 30, 2026.

Management narrowed full-year 2026 revenue growth guidance to 2% to 3%, expects software growth above that range, and expects services growth at or below its low end. The company retained its 29% to 31% adjusted EBITDA margin outlook as an appropriate fourth-quarter range, updated adjusted diluted EPS guidance to $0.31 to $0.34, and continued to model an effective tax rate of 25% to 30%. The key reported tension is between renewed software momentum and continued services pressure, alongside a nine-month loss from continuing operations of $(21.5) million and adjusted EBITDA of $83.1 million versus $84.0 million in the prior-year period.

Management, verbatim

We delivered solid revenue and profit in the quarter, and software revenue grew 11% organically, our first double-digit quarter in two years. We are focused on the disciplined execution required to deliver this performance consistently.

Jon Resnick, Chief Executive Officer

Adjusted EBITDA margin improved to 31.8%, up more than 370 basis points from the second quarter. We generated $30.7 million of cash from continuing operations in the quarter and ended with $214.9 million in cash. With nine months of results reported, we are narrowing our 2026 full year revenue growth range to 2% to 3%.

Faiz Mohammed, Interim Chief Financial Officer

Not in the filing

stated, not guessed
  • Previous-release outlook was not provided; therefore, no comparison of actual results with prior guidance is available.
  • GAAP gross margin was not reported.
  • Free cash flow was not reported.
  • Quarterly operating cash flow was not presented in the cash flow statement; management stated cash from continuing operations in the quarter was $30.7 million.
  • A full-year 2026 revenue dollar range was not reported.
  • Forward-looking GAAP reconciliations for adjusted EBITDA, adjusted EBITDA margin, and adjusted diluted earnings per share were not provided because the Company stated they could not be prepared without unreasonable effort.
  • No dividend declaration or dividend payment was reported.
  • Prior-quarter revenue, bookings, operating income, net income, EPS, and adjusted EBITDA values were not reported for the corresponding metric rows.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Certara is a Nasdaq‑listed provider of model‑informed drug development software.

Company-level read

Ticker impact

$CERTBullishHigh confidence
Context

Certara filed its Q3 2026 earnings, reporting $94.9M revenue and a narrowed net loss of $3.6M versus $4.8M a year ago.

Expected impact

potential modest upside as the market prices in improved loss and double‑digit software growth

Evidence & confidence

First‑report earnings with better loss and software revenue up 11% provide new, material information for traders.

Market effects

Software and life‑science modeling services sector may see renewed interest from investors.

U.S. biotech and software stocks could experience slight lift.

Limited to niche modeling market; no broad macro impact.

Counterpoint

If the market had already priced in the software momentum, the earnings may be a disappointment.

Key entities

  • Certara, Inc.

    Provider of model‑informed drug development solutions.

  • Grant Peterson

    Newly appointed Chief Product Officer.

Every CERT earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$CERTMedAI 8/10

An Idle Mill and Old Open Pits Draw a New Plan in Southern Argentina

Cerrado Gold Inc. (TSX.V: CERT) (OTCQX: CRDOF) acquired a past-producing mine in Argentina for $20M, aiming to restart operations by 2027. The mine previously produced 1.4M gold equivalent ounces, with peak output of 137,500 ounces in 2011. The company plans a $40,000m drill program for a resource estimate, funded by its existing Santa Cruz operation.

$CERTHigh

Certara Software Revenue Jumps 11% as Services Decline

Certara Inc. (CERT) reported Q3 2026 software revenue growth of 11% to $48.8M, while services revenue declined 2% to $46.1M. Total revenue rose 4% to $94.9M, and net loss narrowed to $3.6M. Adjusted EBITDA increased 6% to $30.2M. The company maintained its full-year revenue growth forecast of 2-3% and updated its adjusted earnings outlook to 31-34 cents per share.

$CERTMed

Why Did Certara (CERT) Shares Climb After Its Latest Update?

Certara (CERT) reported Q3 2026 revenue of $94.9M, up from $90.89M a year earlier, with net income of $5.59M. However, nine-month revenue of $282.26M showed a net loss of $58.44M. Shares rose 9.83% in one day and 35.94% in 30 days, with a year-to-date return of 39.36%. The company's fair value is estimated at $8.71, suggesting a 40% overvaluation. Certara's AI-driven platforms and acquisitions aim to boost revenue and margins.

$CERTMed

Certara Inc (CERT) Q3 2026 Earnings Call Highlights: Software Growth Accelerates as Margins Expand

Certara Inc (CERT) reported Q3 2026 earnings with software revenue growth of 11% but services revenue declined 2% YoY to $46.1M. Full-year 2026 revenue growth guidance was narrowed to 2%-3%. CEO Jon Resnick highlighted cost savings exceeding $12M and strong software demand across customer tiers. The company is transitioning to a cloud-based model and investing in AI initiatives, expecting growth in 2027. GAAP net loss was $3.6M, and adjusted EPS remained flat at $0.09 YoY.

$CERTMed

Certara, Inc. Q3 2026 Earnings Call Summary

Certara reported 11% organic software revenue growth in Q3 2026, its first double-digit increase in two years. The company divested its Regulatory and Medical Writing business to focus on high-growth areas and reorganized operations. Management expects 2%-3% full-year revenue growth, with software outperforming services. AI capabilities and APAC market expansion are seen as growth drivers for 2027.